SCHEDULE 13G

Statement of Beneficial Ownership

ORAMED PHARMACEUTICALS INC. Filed 2025-01-17 Acc 0001213900-25-004622

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-05-15 SCHEDULE 13G Statement of Beneficial Ownership
2025-01-22 8-K Material agreement
2025-01-17 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

External

SEC EDGAR (opens in new tab)